Medical Oncology in Beacon Hospital
Clinical research here is focused on neoplasms, with a strong emphasis on breast cancer and breast neoplasms. The studies are designed to help improve treatment options for people with early-stage disease and a higher risk of recurrence, while also exploring ways to better control long-term outcomes.
- Testing new endocrine therapy approaches for ER-positive, HER2-negative breast cancer
- Evaluating whether treatment can reduce the risk of recurrence and distant spread in early breast cancer
At this Dublin site, the work is centered on comparing promising therapies with current standard care to see which options may offer better protection against disease progression.
Breast Cancer Research
The trial portfolio includes studies in oncology that focus on ER+/HER2- breast cancer, especially cases where disease markers suggest a risk of relapse. These trials aim to improve how clinicians prevent metastasis and manage early disease more effectively.
- Assessing imlunestrant against standard adjuvant therapy in early breast cancer
- Studying elacestrant for its potential to delay distant metastasis or death
The research at Beacon Hospital is part of a broader effort to refine breast cancer treatment and support more personalized care for patients with early-stage disease.
